Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment

被引：47
|
作者：
Terao, Toshiki [1 ,2 ]
Minami, Yosuke [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan
[2] Kameda Med Ctr, Dept Internal Med, Div Hematol Oncol, Kamogawa 2968602, Japan
来源：
CELLS | 2019年 / 8卷 / 04期
关键词：
Hedgehog pathway; acute myeloid leukemia; AML; leukemic stem cell; glioma; Smoothened; glasdegib; sonidegib; STEM-CELLS; MYELODYSPLASTIC SYNDROME; GLASDEGIB PF-04449913; CLINICAL-IMPLICATIONS; PHASE IB; GLI; INHIBITOR; MUTATIONS; ACTIVATION; THERAPY;
D O I：
10.3390/cells8040312
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic development. A non-canonical Hh pathway was recently observed in numerous types of solid cancers and hematological malignancies. Although acute myeloid leukemia (AML) is a common and lethal myeloid malignancy, the chemotherapy for AML has not changed in the last three decades. The Hh pathway and other intracellular signaling pathways are important for the tumor cells' cycle or therapeutic resistance of AML cells. In this article, we will review the current trends in Hh pathway inhibitors for treating AML.
引用
收藏
页数：11
相关论文
共 50 条
  • [41] Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy
    Deng, Rong
    Shen, Na
    Yang, Yang
    Yu, Hongliang
    Xu, Shuping
    Yang, Ying-Wei
    Liu, Shujun
    Meguellati, Kamel
    Yan, Fei
    BIOMATERIALS, 2018, 167 : 80 - 90
  • [42] Targeting mitochondrial metabolism in acute myeloid leukemia
    Rex, Madison Rush
    Williams, Robert
    Birsoy, Kivanc
    Llman, Martin S. Ta
    Stahl, Maximillian
    LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 530 - 537
  • [43] Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
    Yang, Xingcheng
    Ma, Ling
    Zhang, Xiaoying
    Huang, Liang
    Wei, Jia
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [44] Targeting transcription factors in acute myeloid leukemia
    Takei, Hisashi
    Kobayashi, Susumu S.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 28 - 34
  • [45] Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL- positive chronic myeloid leukemia
    Zeng, Xian
    Zhao, Hui
    Li, Yubin
    Fan, Jiajun
    Sun, Yun
    Wang, Shaofei
    Wang, Ziyu
    Song, Ping
    Ju, Dianwen
    AUTOPHAGY, 2015, 11 (02) : 355 - 372
  • [46] Gilteritinib for the treatment of patients with FLT3 mutated relapsed or refractory acute myeloid leukemia
    Wang, Eunice S.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (03): : 105 - 112
  • [47] Advances in the pharmacological management of acute myeloid leukemia in adults
    Numan, Yazan
    Abaza, Yasmin
    Altman, Jessica K.
    Platanias, Leonidas C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (13) : 1535 - 1543
  • [48] DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia
    Sun, Huali
    Ren, Yanling
    Zhou, Xinping
    Chen, Qi
    Liu, Yanmei
    Zhu, Chumeng
    Ruan, Yanyun
    Ruan, Hongli
    Tong, Hongyan
    Ying, Shenpeng
    Lin, Peipei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [49] SPRY1 promotes cell proliferation and inhibits apoptosis by activating Hedgehog pathway in acute myeloid leukemia
    Lv, Guiyang
    Wang, Yuanyuan
    Ji, ChunXiao
    Shi, Chunlei
    Li, Ying
    HEMATOLOGY, 2022, 27 (01) : 1 - 10
  • [50] Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway
    Sekulic, Aleksandar
    Mangold, Aaron R.
    Northfelt, Donald W.
    LoRusso, Patricia M.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 218 - 223
12345